IP Library Granted Patent US 11,839,679
Granted Patent B2
US 11,839,679 · App. 17/362,177 · Granted Dec 12, 2023

Gamma-diketones for treatment and prevention of aging skin and wrinkles

Inventors: John Hood (San Diego, CA); Sunil Kumar Kc (San Diego, CA); Osman Kibar (La Jolla, CA); Charlene F. Barroga (San Diego, CA)
Assignee: BioSplice Therapeutics, Inc.
A61K8/4986A61K8/35A61K8/41A61K8/49A61K8/492A61K8/494A61K8/498A61K8/4913A61K8/4926A61K8/4946A61K8/4953A61K8/4973A61K8/69A61K8/70A61Q19/007A61Q19/02A61Q19/08A61K2800/10
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,839,679
App. No.
17/362,177
Granted
Dec 12, 2023
Kind
B2
Abstract

The present disclosure relates to γ-diketone compounds, such as those having the structures: The disclosure also relates to cosmetic or dermopharmaceutical compositions comprising the same, and methods for using the compounds or compositions for improving the aesthetic appearance of a subject's skin, for example, improving one or more of skin tone, radiance, clarity, tautness, skin firmness, plumpness, suppleness, softness, skin texture, skin texturization and moisturization, appearance of skin contours, appearance of hollow cheeks, appearance of sunken, baggy, or dark circles under eyes, skin luster, brightness, skin thickness, and skin elasticity and/or resiliency comprising application of the compounds or compositions disclosed.

Claims (20)

1. A method for improving the aesthetic appearance of a subject's skin, the method comprising administering to the subject an effective amount of a compound which is

or a dermatologically acceptable salt thereof.

2. A method for improving the aesthetic appearance of a subject's skin, the method comprising administering to the skin an effective amount of a cosmetic or dermopharmaceutical composition comprising a compound which is

or a dermatologically acceptable salt thereof, and a dermatologically acceptable excipient.

3. The method of claim 1 , wherein the improvement in aesthetic appearance is improvement in one or more of skin tone, radiance, clarity, tautness, skin firmness, plumpness, suppleness, softness, skin texture, skin texturization and moisturization, appearance of skin contours, appearance of hollow cheeks, appearance of sunken, baggy, or dark circles under eyes, skin luster, brightness, skin thickness, and skin elasticity and/or resiliency.

4. The method of claim 1 , wherein the improvement in aesthetic appearance is the reduction of fine lines or wrinkles.

5. The method of claim 1 , wherein the improvement in aesthetic appearance is the improvement in procollagen and/or collagen production.

6. The method of claim 1 , wherein the improvement in aesthetic appearance is the reduction of discoloration of skin.

7. The method of claim 2 , wherein the cosmetic or dermopharmaceutical composition is a topical composition.

8. The method of claim 2 , wherein the cosmetic composition is intended for use as a non-therapeutic treatment.

9. A method for improving the aesthetic appearance of a subject's skin, the method comprising administering to the subject an effective amount of a compound which is

or a dermatologically acceptable salt thereof.

10. A method for improving the aesthetic appearance of a subject's skin, the method comprising administering to the skin an effective amount of a cosmetic or dermopharmaceutical composition comprising a compound which is

or a dermatologically acceptable salt thereof, and a dermatologically acceptable excipient.

11. The method of claim 9 , wherein the improvement in aesthetic appearance is improvement in one or more of skin tone, radiance, clarity, tautness, skin firmness, plumpness, suppleness, softness, skin texture, skin texturization and moisturization, appearance of skin contours, appearance of hollow cheeks, appearance of sunken, baggy, or dark circles under eyes, skin luster, brightness, skin thickness, and skin elasticity and/or resiliency.

12. The method of claim 9 , wherein the improvement in aesthetic appearance is the reduction of fine lines or wrinkles.

13. The method of claim 9 , wherein the improvement in aesthetic appearance is the improvement in procollagen and/or collagen production.

14. The method of claim 9 , wherein the improvement in aesthetic appearance is the reduction of discoloration of skin.

15. The method of claim 10 , wherein the cosmetic or dermopharmaceutical composition is a topical composition.

16. The method of claim 10 , wherein the cosmetic composition is intended for use as a non-therapeutic treatment.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Mar 12, 2026
From: TMF GROUP NEW YORK, LLC, NOT INDIVIDUALLY BUT SOLELY AS COLLATERAL AGENT
To: BIOSPLICE THERAPEUTICS, INC.
Reel/Frame 075109/0434 →
SECURITY INTEREST Recorded Sep 14, 2022
From: BIOSPLICE THERAPEUTICS, INC.
To: VICKERS VENTURE FUND VI PTE. LTD.; VICKERS VENTURE FUND VI (PLAN) PTE. LTD.; VICKERS-SPLICE CO-INVESTMENT LLC; MED-PATHWAYS II LIMITED
Reel/Frame 061433/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2021
From: HOOD, JOHN; KC, SUNIL KUMAR; KIBAR, OSMAN; BARROGA, CHARLENE F.
To: SAMUMED, LLC
Reel/Frame 056794/0933 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 8, 2021
From: SAMUMED, LLC
To: BIOSPLICE THERAPEUTICS, INC.
Reel/Frame 056805/0177 →
Continuity (5)
Continuation 16534455 · Aug 7, 2019
Continuation 15706908 · Sep 18, 2017
Division 14831456 · Aug 20, 2015
Provisional Application 62039786 · Aug 20, 2014
Related Publication 20220087917A1 · Mar 24, 2022